Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sumitomo Dainippon announces good results from trial of its lead drug

pharmaceutical-technologyJanuary 14, 2019

Tag: Sumitomo Dainippon , schizophrenia , placebo , Latuda

PharmaSources Customer Service